WELLS FARGO & COMPANY/MN

Position in CNTX — Context Therapeutics Inc.

CIK 72971 SAN FRANCISCO, CA

Position in CNTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$47,079

+$46,919 QoQ

Shares Held

84,981

+73159.5% QoQ

Ownership

0.092%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 79 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CNTX ranks #297 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$47,079	84,981	+73159.5%	Shares	Defined	2026-08-14
2024-03-31	$160	116	+1.8%	Shares	Defined	2024-05-10
2023-12-31	$128	114	+5.6%	Shares	Defined	2024-02-09
2023-09-30	$163	108	+0.9%	Shares	Defined	2023-11-13
2023-06-30	$171	107	+3.9%	Shares	Defined	2023-08-15
2023-03-31	$57	103	+2.0%	Shares	Defined	2023-05-12
2022-12-31	$65	101	+2.0%	Shares	Defined	2023-02-13
2022-09-30	$109	99	+43.5%	Shares	Defined	2022-11-14
2022-06-30	$146	69	+7.8%	Shares	Defined	2022-08-12
2022-03-31	$138	64	+93.9%	Shares	Defined	2022-05-16
2021-12-31	$87	33	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.